Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to compare the efficacy and tolerability of ziprasidone versus olanzapine in the treatment of acute mania. An open label extension will further evaluate the efficacy, safety, and tolerability of ziprasidone compared with olanzapine. Study recruitment was stopped due to difficulty in enrolling the targeted number of patients on July 30, 2007. Subjects that were enrolled at the time completed the study as per protocol. There were no safety concerns involved in the decision to stop enrollment. The Last Subject Last Visit was January 10, 2008.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00329108
Study type Interventional
Source Pfizer
Contact
Status Terminated
Phase Phase 4
Start date November 2006
Completion date January 2008

See also
  Status Clinical Trial Phase
Completed NCT03857438 - Correlation of Audiovisual Features With Clinical Variables and Neurocognitive Functions in Bipolar Disorder, Mania
Completed NCT03013400 - Ebselen as an add-on Treatment in Hypo/Mania Phase 2
Completed NCT04420793 - Voice Changes During ECT
Withdrawn NCT03016104 - Magnetic Seizure Therapy vs. Electroconvulsive Therapy for Bipolar Mania N/A
Terminated NCT04058249 - Accelerated Theta Burst Stimulation for Inpatients With Bipolar Disorder N/A
Recruiting NCT06462586 - Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania Phase 3
Not yet recruiting NCT06462612 - Study of Lumateperone in the Treatment of Patients With Bipolar Mania Phase 3
Completed NCT03160664 - Magnetic Seizure Therapy for Bipolar Mania N/A